ARTICLE | Company News
Expergen GmbH, Thallion cancer news
January 21, 2008 8:00 AM UTC
The companies settled a dispute regarding CAP-232, which Caprion Pharmaceuticals Inc. (now Thallion) licensed from Expergen in 2006 (see BioCentury, March 20, 2006). Thallion said Expergen alleged th...